Prognostic factors for gemcitabine-refractory patients with advanced pancreatic cancer: a retrospective analysis of a multicentre study (Anatolian Society of Medical Oncology)

Inal, Ali; Kos, F.; Algin, Efnan; Yildiz, Ramazan; Berk, Veli; ÜNEK, İLKAY; Colak, Dilsen; DANE, FAYSAL; Geredeli, Caglayan; Isikdogan, Abdurrahman

doi:10.5114/wo.2014.43933

Prognostic factors for gemcitabine-refractory patients with advanced pancreatic cancer: a retrospective analysis of a multicentre study (Anatolian Society of Medical Oncology)

Inal A., Kos F. T., Algin E., Yildiz R., Berk V., ÜNEK İ. T., ...More

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, vol.19, no.2, pp.125-129, 2015 (ESCI, Scopus)

Publication Type: Article / Article
Volume: 19 Issue: 2
Publication Date: 2015
Doi Number: 10.5114/wo.2014.43933
Journal Name: WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
Page Numbers: pp.125-129
Keywords: pancreatic cancer, gemcitabine-refractory, patients, prognostic factors
Open Archive Collection: AVESIS Open Access Collection
Dokuz Eylül University Affiliated: Yes

Abstract

Aim of the study: Systemic chemotherapy for patients with pancreatic cancer has limited impact on overall survival (OS). Patients eligible for chemotherapy should be selected carefully. The aim of the study was to search for prognostic factors for survival in patients with gemcitabine (Gem)-refractory or with gemcitabine and cisplatin (GemCis)-refractory advanced pancreatic cancer.